Youming Guo

550 total citations
16 papers, 440 citations indexed

About

Youming Guo is a scholar working on Molecular Biology, Genetics and Biochemistry. According to data from OpenAlex, Youming Guo has authored 16 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Biochemistry. Recurrent topics in Youming Guo's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Youming Guo is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Youming Guo collaborates with scholars based in United States, China and South Korea. Youming Guo's co-authors include Lee Chao, Julie Chao, Grant Bledsoe, Zhirong Yang, Pengfei Li, Pengfei Li, Lin Gao, Jingmei Zhang, Eugene Chang and Pengfei Li and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and Experimental Cell Research.

In The Last Decade

Youming Guo

16 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youming Guo United States 12 235 131 63 48 47 16 440
Meng Shang China 10 236 1.0× 84 0.6× 46 0.7× 66 1.4× 72 1.5× 22 469
Zhanhui Du China 9 210 0.9× 57 0.4× 46 0.7× 26 0.5× 42 0.9× 28 418
Anne Rübsam Germany 10 297 1.3× 61 0.5× 52 0.8× 97 2.0× 41 0.9× 36 888
Boda Zhou China 13 324 1.4× 89 0.7× 21 0.3× 42 0.9× 32 0.7× 44 554
Mohammad Keramatipour Iran 13 260 1.1× 39 0.3× 35 0.6× 26 0.5× 40 0.9× 60 549
Weili Xue China 12 282 1.2× 122 0.9× 23 0.4× 86 1.8× 31 0.7× 23 557
Yongbo Zhao China 15 338 1.4× 179 1.4× 15 0.2× 53 1.1× 42 0.9× 30 635
Yoshiki Higashijima Japan 14 362 1.5× 69 0.5× 22 0.3× 46 1.0× 58 1.2× 24 729
Barbara Schreier Germany 13 272 1.2× 59 0.5× 26 0.4× 32 0.7× 41 0.9× 33 500
Jiangtao Yan China 12 159 0.7× 64 0.5× 19 0.3× 62 1.3× 43 0.9× 23 460

Countries citing papers authored by Youming Guo

Since Specialization
Citations

This map shows the geographic impact of Youming Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youming Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youming Guo more than expected).

Fields of papers citing papers by Youming Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youming Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youming Guo. The network helps show where Youming Guo may publish in the future.

Co-authorship network of co-authors of Youming Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Youming Guo. A scholar is included among the top collaborators of Youming Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youming Guo. Youming Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Tianyu, Liang Wang, Youming Guo, et al.. (2025). Abstract B032: Concurrent mutant KRAS inhibition and Stereotactic Body Radiation Therapy (SBRT) for preclinical KRASG12D-Driven Pancreatic Ductal Adenocarcinoma (PDAC) treatment. Clinical Cancer Research. 31(2_Supplement). B032–B032. 1 indexed citations
2.
Jiang, Dadi, Youming Guo, Tianyu Wang, et al.. (2024). IRE1α determines ferroptosis sensitivity through regulation of glutathione synthesis. Nature Communications. 15(1). 4114–4114. 22 indexed citations
3.
Guo, Youming, et al.. (2023). Safety and Efficacy of Transoral Endoscopic Thyroidectomy Vestibular Approach Versus Conventional Open Thyroidectomy: A Systematic Review and Meta-analysis. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 33(5). 547–555. 1 indexed citations
4.
Xiao, Zhenna, Liang Chang, Jongchan Kim, et al.. (2019). USP37 is a SNAI1 deubiquitinase.. PubMed. 9(12). 2749–2759. 13 indexed citations
5.
Chao, Julie, Youming Guo, & Lee Chao. (2018). Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity. 2018(1). 4138560–4138560. 52 indexed citations
6.
Guo, Youming, Lee Chao, & Julie Chao. (2018). Kallistatin attenuates endothelial senescence by modulating Let‐7g‐mediated miR‐34a‐SIRT1‐eNOSpathway. Journal of Cellular and Molecular Medicine. 22(9). 4387–4398. 26 indexed citations
7.
Yao, Yuyu, Bing Li, Chang Liu, et al.. (2018). Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice. Journal of the American Heart Association. 7(21). e009562–e009562. 15 indexed citations
8.
Chao, Julie, Youming Guo, Pengfei Li, & Lee Chao. (2017). Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen‐Induced HIF‐1‐eNOS‐NO Pathway. Oxidative Medicine and Cellular Longevity. 2017(1). 5262958–5262958. 15 indexed citations
9.
Chao, Julie, Youming Guo, Pengfei Li, & Lee Chao. (2017). Role of Kallistatin Treatment in Aging and Cancer by Modulating miR‐34a and miR‐21 Expression. Oxidative Medicine and Cellular Longevity. 2017(1). 5025610–5025610. 21 indexed citations
10.
Guo, Youming, Qifei Wang, Yue Zhang, et al.. (2017). Molecular mechanisms of anti-oxidant and anti-aging effects induced by convallatoxin inCaenorhabditis elegans. Free Radical Research. 51(5). 529–544. 15 indexed citations
11.
Guo, Youming, Pengfei Li, Lin Gao, et al.. (2017). Kallistatin reduces vascular senescence and aging by regulating microRNA‐34a‐SIRT1 pathway. Aging Cell. 16(4). 837–846. 84 indexed citations
12.
Li, Pengfei, Youming Guo, Grant Bledsoe, et al.. (2016). Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis. Experimental Cell Research. 340(2). 305–314. 50 indexed citations
13.
Guo, Youming, Pengfei Li, Grant Bledsoe, et al.. (2015). Kallistatin inhibits TGF-β-induced endothelial–mesenchymal transition by differential regulation of microRNA-21 and eNOS expression. Experimental Cell Research. 337(1). 103–110. 81 indexed citations
14.
Li, Pengfei, Youming Guo, Grant Bledsoe, et al.. (2015). Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis. Critical Care. 19(1). 200–200. 35 indexed citations
15.
16.
Zhang, Junhu, Youming Guo, Jingang Yang, et al.. (2006). Design and Synthesis of a Novel Peptidomimetic Inhibitor of Caspase-31. Chemical Research in Chinese Universities. 22(2). 225–228. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026